Adline Chem Lab Limited submitted a regulatory filing to the Department of Corporate Services at BSE Limited on August 10, 2026. The disclosure was made pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company intimated that a meeting of its Board of Directors is scheduled to be held on Thursday, 13th August, 2026. The primary agenda for the meeting includes:
- Consideration and approval of the Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2026
- Review of the Limited Review Report by the Statutory Auditors of the Company
- Any other matter with the permission of the Chair
Additionally, the company disclosed that pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the trading window for dealing in shares of the Company has been closed for all Designated Persons and their immediate relatives since 1st July, 2026. The trading window will remain closed until 48 hours after the announcement/declaration of the Unaudited Financial Results for the quarter ended June 30, 2026.
The document was digitally signed by Vrushank Balkrushna Patel, Managing Director (DIN: 05310613), on behalf of Adline Chem Lab Limited.